ASPIRE Gene Therapy for Hemophilia 2017 | Eligibility


Applicants must meet the following requirements. Proposals not meeting the requirements listed below will be rejected.

Academic Eligibility

To be eligible, the Principal Investigator applicant must have a medical / scientific degree (MD, PhD, or equivalent), an advanced nursing degree (MS/PhD/DNP or equivalent), or an advanced degree in Pharmacy (PharmD or equivalent), Physiotherapy (MPT, DPT or equivalent), or Social Work (MSW, DSW, or equivalent).

Note: Current external review panel members are not eligible to apply, either as applicant or co-applicant. Serving as a mentor, however, to an applicant is permitted

Research Requirements

Applicants/Investigators are expected to:
  • Design studies and generate data to address at least one of the Research Areas of interest (see FAQs)
  • Provide a Publication Plan describing submission of abstracts to (a) congress(es) or submission of (a) publication(s) to peer-reviewed journals. All publications must follow ICH guidelines.
  • Complete the study within 24-30 months from the time that the grant is awarded

Criteria for Selection

The ASPIRE Hemophilia award grants will be made by an independent, external expert review panel comprised of experts in hemophilia.

In their evaluation, the Committee members consider:

  • Scientific merit of the research proposal
  • Qualifications of the Applicant
  • Relevance of proposed research to the program's mission
  • Evidence of the Applicant's commitment to an academic research career
  • Evidence of a suitable research environment
Note: A preliminary review of submissions will be completed by Pfizer in order to ensure proposals are within the scope of research areas, and that there are no concerns with the proposed work from a patient safety or intellectual property perspective. If concerns are identified, the proposal may be rejected prior to evaluation by the External Review Committee.

Other Funding

No other government, non-governmental, or industry-sponsored projects may cover the same scope of work as the grant application to the ASPIRE Research Awards Program. However, an ASPIRE Research Award may be related to other funding from foundations or government agencies, as long as there is no direct overlap. In the application, it is the responsibility of the applicant to justify the novelty of the proposal and provide evidence that the application does not overlap with any current or pending funding.

Once awarded, an ASPIRE Research Award cannot be amended upwards with additional funding support from Pfizer (via the standard Investigator Initiated Research [IIR] process or separate competitive grant program), nor can additional drug support above and beyond what is sufficient to complete the original study as reviewed and approved by the External Review Committee be provided. If supplemental funding is required, it must be secured from sources outside of Pfizer. Similarly, an ongoing Pfizer supported standard IIR cannot apply for supplemental funding via a Pfizer-supported competitive grant program.

ASPIRE Research Awards cannot be provided to studies that are already in progress.

Questions

See the Frequently Asked Questions (FAQ) for help.

You may also e-mail questions to Questions.Aspireresearch-Hemophilia_Gene_aTFPI_therapies@pfizer.com